The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity – A longitudinal cohort study
Open accessAbstract
Background&Aims Cancer is a major cause of death in nonalcoholic fatty liver disease (NAFLD). Obesity is a risk factor for cancers; however, the role of NAFLD in this association is unknown. We investigated the effect of NAFLD versus obesity on incident cancers. Methods We identified all incident cases of NAFLD in a US population between 1997–2016. Subjects with NAFLD were matched by age and sex to referent individuals from the same population (1:3) on the index diagnosis date. We ascertained the incidence of cancer after index date until death, loss to follow-up or study end. NAFLD and cancer were defined using a code-based algorithm with high validity tested by medical record review. The association between NAFLD versus obesity and cancer risk was examined using Poisson regression. Results A total of 4,722 NAFLD subjects (age 54, 46% male) and 14,441 age- and sex-matched referent individuals were followed for a median of 8 (range 1–21) years, during which 2,224 incident cancers occurred. NAFLD was associated with 90% higher risk of malignancy: IRR= 1.9 (95%CI 1.3, 2.7). The highest risk increase was noted in liver cancer, IRR=2.8 (95%CI 1.6, 5.1), followed by uterine IRR=2.3 (95%CI 1.4, 4.1), stomach IRR=2.3 (95%CI 1.3, 4.1), pancreas IRR=2.0 (95%CI 1.2, 3.3) and colon cancer IRR=1.8 (95%CI 1.1, 2.8). In reference to non-obese controls, NAFLD was associated with higher risk of incident cancers (IRR=2.0, 95% CI 1.5, 2.9), while obesity alone was not (IRR=1.0, 95%CI 0.8, 1.4). Conclusions NAFLD was associated with increased cancer risk, particularity of gastrointestinal types. In the absence of NAFLD, the association between obesity and cancer risk is small, suggesting that NAFLD may be a mediator of obesity-cancer association.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling
Plummer, M. (2003) · Cited by 4,720
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M. J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., & Tsilidis, K. K. (2017) · BMJ · doi:10.1136/bmj.j477 · Cited by 803
Rocca, W. A., Yawn, B. P., St. Sauver, J. L., Grossardt, B. R., & Melton, L. J. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.012 · Cited by 791
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 790
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Self-citationAdiposity and cancer risk: new mechanistic insights from epidemiology
Renehan, A. G., Zwahlen, M., & Egger, M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3967 · Cited by 654
St. Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., & Rocca, W. A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq482 · Cited by 649
Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system
St Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., Pankratz, J. J., Brue, S. M., & Rocca, W. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys195 · Cited by 613
Covariance Analysis of Censored Survival Data Using Log-Linear Analysis Techniques
Laird, N., & Olivier, D. (1981) · Journal of the American Statistical Association · doi:10.1080/01621459.1981.10477634 · Cited by 577
Canoy, D., Boekholdt, S. M., Wareham, N., Luben, R., Welch, A., Bingham, S., Buchan, I., Day, N., & Khaw, K.-T. (2007) · Circulation · doi:10.1161/circulationaha.106.673756 · Cited by 472
Allen, A. M., Therneau, T. M., Larson, J. J., Coward, A., Somers, V. K., & Kamath, P. S. (2018) · Hepatology · doi:10.1002/hep.29546 · Cited by 370
Self-citationEpidemiologic trends in overweight and obesity
Ogden, C. L., Carroll, M. D., & Flegal, K. M. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00074-4 · Cited by 282 · cited 1×
“The prevalence of obesity has more than doubled in the last 4 decades(6, 7) and as a result, the incidence of nonalcoholic fatty liver disease (NAFLD) has increased substantially(8–10).”
BackgroundSecular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota
Conio, M., Cameron, A. J., Romero, Y., Branch, C. D., Schleck, C. D., Burgart, L. J., Zinsmeister, A. R., Melton, L. J., & Locke, G. R. (2001) · Gut · doi:10.1136/gut.48.3.304 · Cited by 256
Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma
Hori, M., Takahashi, M., Hiraoka, N., Yamaji, T., Mutoh, M., Ishigamori, R., Furuta, K., Okusaka, T., Shimada, K., Kosuge, T., et al. (2014) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2014.5 · Cited by 160
Metabolic Health Reduces Risk of Obesity-Related Cancer in Framingham Study Adults
Moore, L. L., Chadid, S., Singer, M. R., Kreger, B. E., & Denis, G. V. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0240 · Cited by 108
Lashinger, L. M., Malone, L. M., McArthur, M. J., Goldberg, J. A., Daniels, E. A., Pavone, A., Colby, J. K., Smith, N. C. P., Perkins, S. N., Fischer, S. M., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0027 · Cited by 58
The Epidemiology of Ovarian Cancer A Population-Based Study in Olmsted County, Minnesota, 1935–1991
Beard, C., Hartmann, L. C., Atkinson, E. J., O'Brien, P. C., Malkasian, G. D., Keeney, G. L., & Melton, L. J. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00045-9 · Cited by 51
Hastings, K. G., Boothroyd, D. B., Kapphahn, K., Hu, J., Rehkopf, D. H., Cullen, M. R., & Palaniappan, L. P. (2018) · Annals of Internal Medicine · doi:10.7326/m17-0796 · Cited by 51
Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008
Yang, J. D., Kim, B., Sanderson, S. O., Sauver, J. L. S., Yawn, B. P., Pedersen, R. A., Larson, J. J., Therneau, T. M., Roberts, L. R., & Kim, W. R. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.07.001 · Cited by 44
Self-citationRecent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota
Yang, J. D., Mohammed, H. A., Harmsen, W. S., Enders, F., Gores, G. J., & Roberts, L. R. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000810 · Cited by 41
Endometrial Cancer in Olmsted County, MN
Beard, C. M., Hartmann, L. C., Keeney, G. L., Crowson, C. S., Malkasian, G. D., O’Brien, P. C., & Melton, L. J. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00039-3 · Cited by 20
Cited by
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Younossi, Z. M., Kalligeros, M., & Henry, L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0431 · Cited by 960
Current status and future trends of the global burden of MASLD
Miao, L., Targher, G., Byrne, C. D., Cao, Y.-Y., & Zheng, M.-H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.007 · Cited by 781
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Simon, T. G., Roelstraete, B., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Gut · doi:10.1136/gutjnl-2020-322786 · Cited by 673
Targher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00020-0 · Cited by 586
Metadata
- Authors
- Allen, A. M., Hicks, S. B., Mara, K. C., Larson, J. J., & Therneau, T. M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 71
- Issue
- 6
- Pages
- 1229-1236
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2971152979
- Cited by
- 312
- References
- 31
- FWCI
- 20.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.